Research News

$870,000 to help develop stem cell treatments for septic shock, glaucoma, lung injury and muscle degeneration May 9, 2018 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa are bringing discoveries made in the lab closer to human trials and therapies, thanks to five new peer-reviewed research grants from the Ontario Institute for Regenerative Medi

Researchers

Name	Scientific appointment	Diseases, conditions and populations of interest	Research and clinical approaches
Mattar, Pierre PhD	Scientist (Regenerative Medicine)	Ataxia, Autism, Glaucoma, Intellectual disabilities, Macular degeneration, Retinal disease, Vision	Basic research, Bioinformatics, Cell therapy, Epigenetics, Gene expression, Genetics, Genomics, Model organisms, Molecular and cellular biology, Proteomics, Regenerative medicine, Stem cells, Systems biology, Transgenic/knockout models
Thavorn, Kednapa BPharm, MPharm, PhD	Senior Scientist (Clinical Epidemiology)	Cancer, COVID-19, Diabetes, Gastrointestinal disease, Glaucoma, Global health, Health in disadvantaged peoples, Health in older peoples, HIV, Immigrant and refugee health, Population health, Septic shock, Stroke, Thrombosis / thromboembolism, Vision	Clinical research, Cohort studies, Epidemiology, Health economics, Health research methods, Health services research, Knowledge translation and implementation research, Patient engagement, Pharmacy, Public health, Quality Improvement, Systematic reviews
Tsilfidis, Catherine PhD	Senior Scientist (Neuroscience)	Vision, Retinal disease, Glaucoma	Molecular and cellular biology, Disease models

Related Resources

Vision research at The Ottawa Hospital

Department of Ophthalmology at The Ottawa Hospital